Mayo Clinic, Siemens Expand Collaboration For AI-Driven Disease Treatment
Mayo Clinic News Network
|
Contributed by: Kate Gamble
Summary
Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for people with those diseases and expand access to new imaging and interventional technologies.
"Our goal is to make care more precise, less invasive and more responsive to each patient's needs," said Eric Williamson, M.D., professor and chair, Diagnostic Radiology, Mayo Clinic. "By expanding our collaboration, we can bring advanced imaging, artificial intelligence and innovative treatment approaches directly into everyday clinical care, potentially helping patients receive earlier diagnoses, more personalized treatment plans and better outcomes."
Added John Kowal, president and head of the Americas at Siemens Healthineers: "Improving the diagnosis and treatment of neurodegenerative disease and cancer is core to our purpose as a company. Our collaboration with Mayo Clinic creates significant opportunities to help extend the quantity and quality of patients' lives."
